This phenomenon highlights how PD-1/PD-L1 blockade can selectively promote the survival of tumor cell clones that acquire mutations, enabling them to resist the inflammatory pressures exerted by anti-tumor T cells. This evidence concerns the gene CD274 and neoplasm.